CRT 2023
Late-Breaking Trial Session Three
Gregg W. Stone, MD, FACC, MSCAI (he/him/his)
Physician
Mount Sinai
New York, New York, United States
Disclosure(s): Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)
Ron Waksman, MD, MSCAI
Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States
Disclosure information not submitted.
Maurice Buchbinder, MD, FSCAI
Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States
No relationships to disclose
David J. Cohen, MD, FSCAI
Director of Clinical and Outcomes Research
Cardiovascular Research Foundation
New York, New York, United States
Disclosure(s): Abbott Inc: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Brain-Q, Inc: Grant/Research Support (Ongoing); Corvia Medical: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing); Impulse Dynamics: Consultant (Ongoing); I-Rhythm, Inc: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); MyoKardia: Consultant (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)
Gregory P. Fontana, MD (he/him/his)
Director, CardioVascular Institute
Hospital Corporation of America
Thousand oaks, United States
Disclosure(s): Abbott: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Committee/Planning Member (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing), Scientific Advisory Board (Ongoing); Edwards Lifesciences LLC: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Scientific Research Study Investigator (Ongoing); Highlife Medical: Clinical Trial Investigator (Ongoing), Scientific Research Study Investigator (Ongoing); LAMINAR: Scientific Research Study Investigator (Ongoing); medtronic: Advisor (Ongoing), Advisor or Review Panel Member (Ongoing), Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing), Scientific Research Study Investigator (Ongoing); PiCardia: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Scientific Research Study Investigator (Ongoing)
Howard C. Herrmann, MD, FACC, MSCAI
Director, Interventional Cardiology and Cardiac Cath Labs
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Samir R. Kapadia, MD, FSCAI
Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States
Disclosure(s): No relevant disclosure to display
Michael J. Reardon, MD
Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States
Disclosure(s): Abbott Medical: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)
Moritz C. Wyler von Ballmoos, MD, PhD, MPH
Associate Professor
University Hospital Zurich
Houston, Texas, United States
Disclosure(s): Boston Scientific Corporation: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing)
Steven J. Yakubov, MD, FACC, MSCAI
System/Medical Chief - Structural Heart Disease
OhioHealth/Riverside Methodist Hospital
Columbus, Ohio, United States
Disclosure(s): BioStar: Consultant (Ongoing); Boston Scientific: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Foldax: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing)